Diabetes drug shows slight effect on dementia in German study
Older Germans who took Takeda Pharmaceutical Co. (4502)'s diabetes medicine Actos were slightly less likely to develop dementia, according to a study that may do little to resolve questions about the drug's usefulness. The German Center for Neurodegenerative Diseases followed 145,717 people of age 60 or older who were members of the country's biggest public insurer from 2004 to 2010, tracking whether they developed dementia and also whether they took Actos, once the world's best-selling diabetes medicine. Those on the drug were 6 percent less likely to develop dementia, according to results presented at the Alzheimer's Association International Conference in Copenhagen.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063